Delcath Systems (DCTH) Cash & Equivalents Growth (1y) (2011 - 2026)
Delcath Systems (DCTH) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 72.43% |
| 10 | Delcath Systems | 603.34 Mn | 507.42 Mn | 26.15 Mn | 38.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.06% |
| Mar 31, 2026 | 223.36% |
| Dec 31, 2025 | 34.07% |
| Sep 30, 2025 | 402.86% |
| Mar 31, 2025 | 25,452.00% |
| Dec 31, 2024 | 64,724.00% |
| Sep 30, 2024 | -79.45% |
| Mar 31, 2024 | -99.79% |
| Dec 31, 2023 | -98.80% |
| Sep 30, 2023 | 311.58% |
| Jun 30, 2023 | -99.51% |
| Mar 31, 2023 | 483.52% |
| Dec 31, 2022 | -81.80% |
| Sep 30, 2022 | 136.83% |
| Jun 30, 2022 | 6,656.95% |
| Mar 31, 2022 | 8,202.00% |
| Dec 31, 2021 | -20.20% |
| Sep 30, 2021 | -61.91% |
| Jun 30, 2021 | -99.06% |
| Mar 31, 2021 | -72.38% |